Highly Effective Use of a Medical Affairs Team with Medical Science Liaison-delivered Education: The SMART-MSL Study
Author(s)
Sheena Merwine, PharmD1, Janelle O. Poyant2, Brianne M. Ritchie, PharmD1, Victor Rivera, PharmD1, Jacqueline Chaben, PharmD, RN1, Stacy Revelle, PharmD1, Nouran Salem, PharmD1, Doug Wylie, PharmD1, Steven Ness, DO1, Hijrah El-Sabae, PharmD1.
1Chiesi, USA, Cary, NC, USA, 2MSL, Chiesi, Boston, MA, USA.
1Chiesi, USA, Cary, NC, USA, 2MSL, Chiesi, Boston, MA, USA.
Presentation Documents
OBJECTIVES: Cangrelor is an IV P2Y12 platelet inhibitor used in adjunct to PCI. Registry data highlight interhospital variability in both practice patterns and adherence to established treatment strategies. Patients who received the established treatment strategy had numerically lower MACE and bleeding events. Our study sought to describe the impact of medical science liaison (MSL)-delivered educational sessions surrounding the on-label use of cangrelor to help ensure effective and efficient antiplatelet therapy for patients.
METHODS: Education was provided to HCPs who take part in the operational workflow of ordering, preparing, and/or administering cangrelor for PCI. HCPs were invited to complete an anonymous electronic survey following the discussion surrounding optimization opportunities and related clinical outcomes.
RESULTS: Inclusive and multidisciplinary educational sessions were conducted in-person (58%) or virtually (42%). Of the 130 survey participants, the majority were pharmacists and nurses (59% and 19%, respectively), in addition to prescribers and ancillary staff. The overall Net Promoter Score was 72 (50-80 = excellent). The vast majority (92%) of HCPs found the content relevant to their practice, and the learning format was rated as helpful 95% of the time.Survey respondents rated the MSL-delivered educational activity favorably. HCPs appreciated the ability to provide improved patient care (90%) and intend to change their practice behaviors accordingly (70%). The education facilitated identification of opportunities to overcome operational barriers (91%) and increased awareness of established treatment strategies (95%). Survey respondents agreed that MSLs were knowledgeable and presented fair and balanced information >96% of the time.
CONCLUSIONS: A Medical Affairs team can maximize organizational efforts in customer satisfaction by engaging relevant healthcare team members and product-users to find feasible solutions for their individual operations. We can empower customers with additional educational tools and resources to overcome institutional barriers and demonstrate our commitment to improving patient outcomes and shared value.
METHODS: Education was provided to HCPs who take part in the operational workflow of ordering, preparing, and/or administering cangrelor for PCI. HCPs were invited to complete an anonymous electronic survey following the discussion surrounding optimization opportunities and related clinical outcomes.
RESULTS: Inclusive and multidisciplinary educational sessions were conducted in-person (58%) or virtually (42%). Of the 130 survey participants, the majority were pharmacists and nurses (59% and 19%, respectively), in addition to prescribers and ancillary staff. The overall Net Promoter Score was 72 (50-80 = excellent). The vast majority (92%) of HCPs found the content relevant to their practice, and the learning format was rated as helpful 95% of the time.Survey respondents rated the MSL-delivered educational activity favorably. HCPs appreciated the ability to provide improved patient care (90%) and intend to change their practice behaviors accordingly (70%). The education facilitated identification of opportunities to overcome operational barriers (91%) and increased awareness of established treatment strategies (95%). Survey respondents agreed that MSLs were knowledgeable and presented fair and balanced information >96% of the time.
CONCLUSIONS: A Medical Affairs team can maximize organizational efforts in customer satisfaction by engaging relevant healthcare team members and product-users to find feasible solutions for their individual operations. We can empower customers with additional educational tools and resources to overcome institutional barriers and demonstrate our commitment to improving patient outcomes and shared value.
Conference/Value in Health Info
2025-05, ISPOR 2025, Montréal, Quebec, CA
Value in Health, Volume 28, Issue S1
Code
HSD57
Topic
Health Service Delivery & Process of Care
Disease
SDC: Cardiovascular Disorders (including MI, Stroke, Circulatory)